Chicago Partners Investment Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,163
Closed -$339K 713
2023
Q2
$339K Sell
7,163
-1,134
-14% -$39.2K 0.02% 505
2023
Q1
$272K Buy
+8,297
New +$246K 0.02% 525
2022
Q4
Sell
-6,588
Closed -$204K 663
2022
Q3
$204K Buy
+6,588
New +$120K 0.01% 533

Chicago Partners Investment Group's DICE Position: Q3 2023 in Review

Chicago Partners Investment Group sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 7,163 shares — an estimated $339K sold.

Chicago Partners Investment Group first reported a position in DICE in Q3 2022 and held it in 3 quarters. The position peaked at $339K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Chicago Partners Investment Group reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Chicago Partners Investment Group sold 7,163 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $339K.
  • Chicago Partners Investment Group first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Chicago Partners Investment Group's DICE Therapeutics, Inc. Common Stock position peaked at $339K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Chicago Partners Investment Group's 13F filing for Q3 2023, filed 26 Oct 2023.